Outcomes of COVID-19 among patients with liver disease

doi:10.3748/wjg.v29.i5.815

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3262)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

192

WORD

HTML

1807

Figures (1-1)

398

Sum=2470

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

240

Download

552

Sum=792

Feb 7, 2023 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 7, 2023; 29(5): 815-824
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.815

Open in New Tab Full Size Figure Download Figure

Figure 1 Prognostic factors in COVID-19 patients with liver disease. BMI: Body mass index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease; MAFLD: Metabolic-associated fatty liver disease.

Citation: Vujčić I. Outcomes of COVID-19 among patients with liver disease. World J Gastroenterol 2023; 29(5): 815-824
URL: https://www.wjgnet.com/1007-9327/full/v29/i5/815.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i5.815